Skip to main content
SpringerLink
Log in

Maladie des emboles de cholestérol

  • Chapter
Maladies rares en médecine d’urgence

Part of the book series: Références en médecine d’urgence. Collection de la SFMU ((REFERMED))

  • 1181 Accesses

Résumé

La maladie des emboles de cholestérol (MEC) est une maladie athéro-embolique systémique, pouvant compliquer la maladie athéromateuse dans ses formes les plus sévères. Elle peut atteindre plusieurs organes, tels que le rein, le système nerveux central, l’œil, l’appareil digestif ou la peau, et met souvent en jeu le pronostic vital. Son diagnostic est difficile et souvent trop tardif, car le tableau clinique est hétérogène et les cliniciens sont peu sensibilisés à ce problème.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685–95

    Article  PubMed  CAS  Google Scholar 

  2. Fine MJ, Kapoor W, Falanga V (1987) Cholesterol crystal emboleization: a review of 221 cases in the English literature. Angiology 38: 769–84

    Article  PubMed  CAS  Google Scholar 

  3. Lye WC, Cheah JS, Sinniah R (1993) Renal cholesterol emboleic disease. Case report and review of the literature. Am J Nephrol 13: 489–93

    Article  PubMed  CAS  Google Scholar 

  4. Thadhani RI, Camargo CA Jr., Xavier RJ, Fang LS, Bazari H (1995) Atheroemboleic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore) 74: 350–8

    Article  CAS  Google Scholar 

  5. Belenfant X, Meyrier A, Jacquot C (1999) Supportive treatment improves survival in multivisceral cholesterol crystal emboleism. Am J Kidney Dis 33: 840–50

    Article  PubMed  CAS  Google Scholar 

  6. Scolari F, Ravani P, Pola A et al. (2003) Predictors of renal and patient outcomes in atheroemboleic renal disease: a prospective study. J Am Soc Nephrol 14: 1584–90

    Article  PubMed  Google Scholar 

  7. Borissoff JI, Spronk HM, Ten Cate H (2011). The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364: 1746–60

    Article  PubMed  CAS  Google Scholar 

  8. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A, Cholesterol Emboleism Study I (2003) The incidence and risk factors of cholesterol emboleization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42: 211–6

    Article  PubMed  Google Scholar 

  9. Scolari F, Ravani P (2010) Atheroemboleic renal disease. Lancet 375: 1650–60

    Article  PubMed  Google Scholar 

  10. Moolenaar W, Lamers CB (1996) Cholesterol crystal emboleisation to the alimentary tract. Gut 38: 196–200

    Article  PubMed  CAS  Google Scholar 

  11. Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J (2008) Microembolei composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition. Stroke 39: 2354–61

    Article  PubMed  CAS  Google Scholar 

  12. Mayo RR, Swartz RD (1996) Redefining the incidence of clinically detectable atheroemboleism. Am J Med 100: 524–9

    Article  PubMed  CAS  Google Scholar 

  13. Teja K, Crampton RS (1985) Intramural coronary arteritis from cholesterol embolei: a rare cause of unstable angina preceding sudden death. Am Heart J 110: 168–70

    Article  PubMed  CAS  Google Scholar 

  14. Kasinath BS, Lewis EJ (1987) Eosinophilia as a clue to the diagnosis of atheroemboleic renal disease. Arch Intern Med 147: 1384–5

    Article  PubMed  CAS  Google Scholar 

  15. Scolari F, Ravani P, Gaggi R et al. (2007) The challenge of diagnosing atheroemboleic renal disease: clinical features and prognostic factors. Circulation 116: 298–304

    Article  PubMed  Google Scholar 

  16. Woolfson RG, Lachmann H (1998) Improvement in renal cholesterol embolei syndrome after simvastatin. Lancet 351: 1331–2

    Article  PubMed  CAS  Google Scholar 

  17. Mann SJ,SosTA (2001) Treatment of atheroemboleization with corticosteroids. Am J Hypertens 14: 831–4

    Article  PubMed  CAS  Google Scholar 

  18. Nakayama M, Nagata M, Hirano T et al. (2006) Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal emboleism. Clin Nephrol 66: 232–9

    PubMed  CAS  Google Scholar 

  19. Boero R, Pignataro A, Rollino C, Quarello F (2000) Do corticosteroids improve survival in acute renal failure due to cholesterol atheroemboleism? Nephrol Dial Transplant 15: 441

    Article  PubMed  CAS  Google Scholar 

  20. Siemons L, van den Heuvel P, Parizel G, Buyssens N, De Broe ME, Cuykens JJ (1987) Peritoneal dialysis in acute renal failure due to cholesterol emboleization: two cases of recovery of renal function and extended survival. Clin Nephrol 28: 205–8

    PubMed  CAS  Google Scholar 

  21. Theriault J, Agharazzi M, Dumont M, Pichette V, Ouimet D, Leblanc M (2003) Atheroemboleic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract 94: c11–8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de néphrologie, Hôpital Européen Georges Pompidou - AP-HP, 75015, Paris, France

    A. Karras & C. Trivin

Authors
  1. A. Karras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Trivin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Karras .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Karras, A., Trivin, C. (2013). Maladie des emboles de cholestérol. In: Maladies rares en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. Springer, Paris. https://doi.org/10.1007/978-2-8178-0350-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0350-0_12

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0349-4

  • Online ISBN: 978-2-8178-0350-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation